IP Library › Assignment 049400/0483
Patent Assignment
Reel/Frame 049400/0483

Merger and Change of Name

Recorded: 2019-06-06 Pages: 3
Assignors
PROTIVA BIOTHERAPEUTICS, INC.
Executed: 2018-01-01
ARBUTUS BIOPHARMA CORPORATION
Executed: 2018-01-01
Assignee
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property (1)
Compositions and Methods for Silencing Hepatitis B Virus Gene Expression
Application: 15/515,952 →
Publication: US 2018/0016583
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 26, 2017
From: CROSS, JENNIFER L.; DHILLON, AMMEN P.; LEE, AMY C. H.; MACLACHLAN, IAN
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 042818/0636 →